157 related articles for article (PubMed ID: 16840182)
1. Anti-angiogenesis and diffuse large B-cell lymphoma: a new treatment opportunity?
Portlock C
Leuk Lymphoma; 2006 Jun; 47(6):961-2. PubMed ID: 16840182
[No Abstract] [Full Text] [Related]
2. CHOP plus rituximab--balancing facts and opinion.
Cheson BD
N Engl J Med; 2002 Jan; 346(4):280-2. PubMed ID: 11807154
[No Abstract] [Full Text] [Related]
3. Immunochemotherapy is the standard of care in elderly patients with diffuse large B-cell lymphoma.
Coiffier B; Salles G
Blood; 2004 Sep; 104(5):1584-5; author reply 1585-6. PubMed ID: 15317734
[No Abstract] [Full Text] [Related]
4. Intra-vascular large B-cell lymphoma revealed by a nephrotic syndrome: a one year remission induced by a high frequency CHOP and rituximab.
Girard T; Nochy D; Montravers F; Der Sahakian G; Fior R; Galanaud P; Boué F
Leuk Lymphoma; 2004 Aug; 45(8):1703-5. PubMed ID: 15370230
[TBL] [Abstract][Full Text] [Related]
5. Rituximab, bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: safety, biomarker and pharmacokinetic analysis.
Ganjoo KN; An CS; Robertson MJ; Gordon LI; Sen JA; Weisenbach J; Li S; Weller EA; Orazi A; Horning SJ
Leuk Lymphoma; 2006 Jun; 47(6):998-1005. PubMed ID: 16840188
[TBL] [Abstract][Full Text] [Related]
6. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Coiffier B; Lepage E; Briere J; Herbrecht R; Tilly H; Bouabdallah R; Morel P; Van Den Neste E; Salles G; Gaulard P; Reyes F; Lederlin P; Gisselbrecht C
N Engl J Med; 2002 Jan; 346(4):235-42. PubMed ID: 11807147
[TBL] [Abstract][Full Text] [Related]
7. R2-CHOP vs R-CHOP for diffuse large B-cell lymphoma.
Fowler NH
Clin Adv Hematol Oncol; 2014 Sep; 12(9):608-10. PubMed ID: 25654483
[No Abstract] [Full Text] [Related]
8. BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?
Dunleavy K; Davis RE; Landgren O; Staudt LM; Wilson WH
Blood; 2007 Jan; 109(2):843-4; discussion 844-5. PubMed ID: 17210865
[No Abstract] [Full Text] [Related]
9. [Spindle cell variants of diffuse large B cell lymphoma: report of 2 cases].
Wang JC; Shi DR; Fu XL; Lu CL; Lu WP
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):55-6. PubMed ID: 15796885
[No Abstract] [Full Text] [Related]
10. Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab.
Yamagata M; Murohisa T; Tsuchida K; Okamoto Y; Tsunoda S; Nakamura M; Kusano K; Majima Y; Kuniyoshi T; Iijima M; Sugaya H; Hiraishi H
Leuk Lymphoma; 2007 Feb; 48(2):431-3. PubMed ID: 17325912
[No Abstract] [Full Text] [Related]
11. Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP.
Lin PC; Hsiao LT; Poh SB; Wang WS; Yen CC; Chao TC; Liu JH; Chiou TJ; Chen PM
Ann Hematol; 2007 Feb; 86(2):95-100. PubMed ID: 17031689
[TBL] [Abstract][Full Text] [Related]
12. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma: report of a case in the oral cavity.
Jaradat JM; Potluri A; Bilodeau EA
Indian J Dent Res; 2013; 24(3):384-6. PubMed ID: 24025890
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
Micallef IN; Kahl BS; Maurer MJ; Dogan A; Ansell SM; Colgan JP; Geyer S; Inwards DJ; White WL; Habermann TM
Cancer; 2006 Dec; 107(12):2826-32. PubMed ID: 17099879
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy.
Takács I; Eros N; Bene I; Bozsó F; Tordai L; Károlyi Z; Radványi G; Matolcsy A
Ann Hematol; 2004 Sep; 83(9):608-10. PubMed ID: 15205915
[No Abstract] [Full Text] [Related]
15. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
[TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
Copson E
Clin Evid; 2006 Jun; (15):30-44. PubMed ID: 16973004
[No Abstract] [Full Text] [Related]
17. Primary large B-cell lymphoma of the bone marrow.
Hishizawa M; Okamoto K; Chonabayashi K; Kaneko H; Watanabe M; Tsudo M
Br J Haematol; 2007 Feb; 136(3):351. PubMed ID: 17233843
[No Abstract] [Full Text] [Related]
18. High-risk diffuse large B-cell lymphoma: can we do better than rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone?
George A; Tam CS; Seymour JF
Leuk Lymphoma; 2013 Dec; 54(12):2575-6. PubMed ID: 23597141
[No Abstract] [Full Text] [Related]
19. Cyclin D1-positive diffuse large B-cell lymphoma.
Rodriguez-Justo M; Huang Y; Ye H; Liu H; Chuang SS; Munson P; Prada-Puentes C; Kim I; Du MQ; Bacon CM
Histopathology; 2008 Jun; 52(7):900-3. PubMed ID: 18494615
[No Abstract] [Full Text] [Related]
20. Value of positron emission tomography scan in staging cancers, and an unusual presentation of acute myeloid leukemia. Case 1. Demonstration of CNS lymphoma by positron emission tomography scan affects management.
Harandi A; Ghesani M; Polosajian L; Tupper T; Sara G
J Clin Oncol; 2004 Jul; 22(14):2964-6. PubMed ID: 15254064
[No Abstract] [Full Text] [Related]
[Next] [New Search]
